CGMPs practices

Many pharmaceutical firms have implemented operator and analyst qualification programs in which personnel are trained in the specific techniques, technologies, and equipment that they use in their work as well as in general proper implementation of CGMP practices in their work environment. There are still firms not fully familiarizing their staff with all aspects of their assigned tasks before they are asked to carry them out, however. This... 

Current good manufacturing practices (cGMPs) Practices or procedures that the regulatory agencies currently consider to be the standard, accepted manner of operation for products made for human consumption either in a clinical or commercial venue. 

Other offices within ODER may become involved in the review process via consults. Eor example, the Office of Epidemiology and Biostatistics analyzes statistical data, the Office of Research Resources provides bioavailabiHty reviews, and the Office of Compliance determines from the results of inspections whether the firms meet EDA s Current Good Manufacturing Practice (cGMP) regulations. Advisory committees composed of independent experts are often asked to meet and further analyze the data. Often they also advise as to what additional data and information may be needed. After PDA s review is completed, PDA issues either a Summary Basis of Approval (SBA) for the dmg or a recommendation against approval. If approved, PDA releases the SBA and a summary of the safety and effectiveness data to the general pubHc. 

In 2002, the FDA announced a significant new initiative, Pharmaceutical Current Good Manufacturing Practices (cGMPs) for the 21st Century . The purposes of this... 

The current Good Manufacturing Practice (cGMP) regulations are guidelines that FDA requires a pharmaceutical manufacturer to meet. Compliance with the cGMPs is a prerequisite for the approval of NDAs, INDs, and antibiotic forms. General areas in which... 

Current good manufacturing practices (CGMPs) indicate that a parenteral manufacturer should confirm supplier certification on packaging components. The following characteristics are usually monitored for a specific elastomeric formulation ... 

Because of the success of the CGMP laws, a new line of thought was developed that involved the subject of good laboratory practices. On December 22, 1978, the regulations entitled Non-clinical Laboratory Studies were issued in the Federal Register [21]. These regulations, which became known as Good Laboratory Practice, are involved in the evaluation of nonclinical laboratory studies. 

See also Current good manufacturing practices (cGMPs)... 

---